Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
US11920139B2 · kind B2 · utility
0Cited by
54References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 14, 2021 |
| Grant date | Mar 5, 2024 |
| Priority date | — |
| Expiry date | Oct 14, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/523
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compositions and methods for making and using recombinant bacteria that are capable of regulated attenuation and/or regulated expression of one or more antigens of interest.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.